Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
BioNTech opens the hood on its AI ambitions, and they're not just for mRNA
7 months ago
R&D
AI
AstraZeneca, AbbVie, PhRMA lose court battle over Louisiana 340B law
7 months ago
Pharma
FDA+
Gilead licenses HIV shot to six generic manufacturers, but falls short of access sought by advocates
7 months ago
Pharma
Manufacturing
EMA looks to make its drug approval processes more efficient
7 months ago
FDA+
J&J budgets over $2B for new North Carolina biologics facility
7 months ago
Pharma
Manufacturing
A blow to Humana’s Medicare Advantage quality ratings could tank its revenue by billions
7 months ago
Health Tech
Teladoc COO resigns amid executive shuffle
7 months ago
People
Health Tech
Wave’s new capital extends cash runway into 2027, CEO says
7 months ago
R&D
Frazier adds $630M to public fund to 'take advantage of market volatility'
7 months ago
Financing
Scoop: Founding CEO leaves Atomwise, casting doubt over a once high-flying AI startup
7 months ago
People
AI
Exclusive: Medicare navigation startup Connie Health is buying a Redesign Health-backed rival
7 months ago
Deals
Health Tech
Lilly invests $4.5B in new Indiana site to bring clinical manufacturing in-house
7 months ago
R&D
Pharma
Exclusive: After discovering antibiotics with AI, a 31-year-old first-time CEO raises $17M to fight aging
7 months ago
Startups
AI
Triveni to take experimental eczema drug to the clinic, backed by new $115M financing round
7 months ago
Financing
Startups
UK biotech bags $43M in Series A to move Huntington's drug into first human study
7 months ago
Financing
R&D
GSK’s ViiV stops development of Phase 2 HIV antiviral
7 months ago
R&D
Pharma
Updated: Senators question FDA and FTC over patent and PBM reforms
7 months ago
FDA+
Law
Judge keeps Amgen's $10.7B tax liability suit alive
7 months ago
Pharma
Law
J&J and Bayer to lay off almost 300 staffers in New Jersey
7 months ago
People
Pharma
Biohaven aims to raise $250M; Activist investor's stake in Galapagos exceeds 10%
7 months ago
News Briefing
Targeting Novartis' Scemblix, Enliven lays out case for leukemia drug in early results
7 months ago
R&D
Gritstone bio’s stock dips after it shares more data from failed Phase 2 colorectal cancer trial
7 months ago
R&D
CAMP4, preparing for IPO, announces partnership with BioMarin
7 months ago
Startups
Deals
CVS considers breaking up the company as investors urge turnaround — reports
7 months ago
Health Tech
First page
Previous page
87
88
89
90
91
92
93
Next page
Last page